| Issue |
Section |
Title |
File |
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Results of allogeneic hematopoietic stem cell transplantation from haploidentical donors in children and adolescents with high-risk acute leukemia using unmanipulated graft. Ten years experience of R.G.Memorial institute of children oncology, hematology and transplantation. CIC 725 |
(Rus)
|
| Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Acute GvHD prophylaxis with posttransplant cyclophosphamide after hematopoietic stem cell transplantation (HSCT) for non-malignant disorders |
(Rus)
|
| Vol 17, No 3 (2018) |
PROMISING STUDIES |
Paroxysmal nocturnal hemoglobinuria in children and adults: comparative clinical profile and long-term prognosis |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
Invasive candidiasis in children after hematopoietic stem cell transplantation |
(Rus)
|
| Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
Brentuximab vedotin in the treatment of children and adolescents with refractory and relapsed Hodgkin's lymphoma |
(Rus)
|
| Vol 19, No 2 (2020) |
ПЕРЕДОВАЯ СТАТЬЯ |
Hematopoietic stem cell transplantation in children in Russia: a brief overview of activity in 2015–2018 |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
The results of allogeneic hematopoietic stem cell transplantation from a matched unrelated and haploidentical donors in children with high-risk infant leukemia in first and second remissions |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
The influence of various doses of busulfan in conditioning regimes on outcome of allogeneic hematopoietic stem cell transplantation in children with acute myeloid leukemia |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
Factors of bacteriuria in children and young adults following hematopoietic stem cell transplantation |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
An evaluation of the efficacy of allogeneic hematopoietic stem cell transplantation in patients with mucopolysaccharidosis type I (Hurler syndrome): the experience of the R.M. Gorbacheva Research Institute for Pediatric Oncology, Hematology and Transplantation |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
The use of checkpoint inhibitors in children with non-Hodgkin lymphomas |
(Rus)
|
| Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
The complex intensive therapy regimen as curative therapy in patients with primary-resistant and relapsed neuroblastoma: R.M. Gorbacheva Memorial Institute for Children Oncology, Hematology and Transplantation experience |
(Rus)
|
| Vol 20, No 1 (2021) |
ORIGINAL ARTICLES |
Allogeneic hematopoietic stem cell transplantation in children with lymphoblastic lymphoma |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
High-dose polychemotherapy with autologous hematopoietic stem cell transplantation in children with non-Hodgkin lymphomas |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
The results of multicenter treatment of atypical teratoid/rhabdoid tumors of the central nervous system in children under 3 years |
(Rus)
|
| Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
The results of multicenter treatment of atypical teratoid/rhabdoid tumors of the central nervous system in children under 3 years |
(Rus)
|
| Vol 21, No 2 (2022) |
ORIGINAL ARTICLES |
Autologous hematopoietic stem cell transplantation in children with relapsed or refractory Hodgkin lymphoma |
(Rus)
|
| Vol 21, No 4 (2022) |
ORIGINAL ARTICLES |
Immunotherapy of high-risk infant acute lymphoblastic leukemia using blinatumomab and infusion of donor lymphocytes |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
Molecular genetic and cytofluorimetric prognostic factors in the development of acute myeloid leukemia relapse in children after allogeneic hematopoietic stem cell transplantation |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
An analysis of the efficacy of graft-versus-host disease prophylaxis with post-transplant cyclophosphamide in children with acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation from HLA-matched and partially-matched unrelated donors |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
The prognostic value of HLA loss of heterozygosity after allogeneic hematopoietic stem cell transplantation in children with relapsed acute leukemia |
(Rus)
|
| Vol 22, No 3 (2023) |
ORIGINAL ARTICLES |
A successful second allogeneic hematopoietic stem cell transplantation from an alternative donor in a patient with loss of HLA heterozygosity relapse of juvenile myelomonocytic leukemia: case series analysis |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
Inotuzumab ozogamicin as a bridging therapy to allogeneic hematopoietic stem cell transplantation in children with refractory/relapsed B-cell acute lymphoblastic leukemia |
(Rus)
|
| Vol 23, No 2 (2024) |
ORIGINAL ARTICLES |
The clinical course of the novel coronavirus disease in children after allogeneic hematopoietic stem cell transplantation |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Immunoadoptive effect of donor lymphocyte infusion-induced acute graft-versus-host disease in children with acute leukemia |
(Rus)
|
